Incidence and predisposing factors of chalazion

Authors

  • Alaa Alsammahi College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
  • Ziyad Aljohani College of Medicine, Ibn Sina National College, Jeddah, Saudi Arabia
  • Nafisah Jaad College of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia
  • Omamah Abu Daia College of Medicine, King Khalid University, Abha, Saudi Arabia
  • Majed Aldayhum College of Medicine, King Khalid University, Abha, Saudi Arabia
  • Mohammed Almutairi College of Medicine, Qassim University, Qassim, Saudi Arabia
  • Mohammad Basendwah Department of Ophthalmology, South Qunfudah Hospital, Qunfudah, Saudi Arabia
  • Reham Alzahrani College of Medicine, Taif University, Taif, Saudi Arabia
  • Muna Alturki Department of Histopathology, King Abdulaziz Hospital, Jeddah, Saudi Arabia

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20184253

Keywords:

Chalazion, Incidence, Risk factors, Predisposing factors

Abstract

Chalazion is one of the most common eyelid masses seen by ophthalmologists in outpatient clinics. It presents with slowly growing painless cystic lesion affecting eyelids. Chalazion arises due to obstruction of the meibomian gland ducts leading to retained secretion. The exact incidence of chalazion is variable among the studies and it differs depending on certain predisposing factors. Many factors ae known to predispose to chalazion formation including hormonal changes during puberty and pregnancy, viral and bacterial infection, rosacea, exposure to air pollutants, poor eyelid hygiene, chronic blepharitis, seborrheic dermatitis, eyelid trauma, immune deficiency states, eyelid trauma, hyperlipidemia, tuberculosis, and leishmaniasis. This article will review these factors as well as the incidence of chalazion.

References

Arbabi EM, Kelly RJ, Carrim ZI. Chalazion. Praxis (Bern 1994). 2011;100(8):479-80.

Unal M. Chalazion treatment. Orbit. 2008;27(6):397-8.

Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol. 1996;40(5):343-67.

Donaldson MJ, Gole GA. Amblyopia due to Inflamed Chalazion in a 13-Month Old Infant. Clin Experimental Ophthalmol. 2005;33:332-3.

Khurana AK, Ahluwalia BK, Rajan C. Chalazion therapy. Acta Ophthalmol. 2009;66(3):352-4.

Devlioti D, Tsintarakis T, Milioti G, Seitz B, Kasmann-Kellner B. Unusual course of a chalazion. Ophthalmologe. 2015;112(3):269-71.

Chang M, Park J, Kyung SE. Extratarsal presentation of chalazion. Int Ophthalmol. 2017;37(6):1365-7.

Al-Faky YH. Epidemiology of benign eyelid lesions in patients presenting to a teaching hospital. Saudi J Ophthalmol. 2012;26(2):211-6.

Kersten RC, Ewing-Chow D, Kulwin DR, Gallon M. Accuracy of Clinical Diagnosis of Cutaneous Eyelid Lesions. Ophthalmology. 1997;104(3):479-84.

Hsu HC, Lin HF. Eyelid tumors in children: A clinicopathologic study of a 10-year review in Southern Taiwan. Ophthalmologica. 2004;218(4):274-7.

Ni Z. Histopathological classification of 3,510 cases with eyelid tumor. Zhonghua Yan Ke Za Zhi. 1996;32(6):435-7.

Mindy Ann Smith AEMJ. Hordeolum and Chalazion. In: The Color Atlas of Family Medicine. Second. McGraw-Hill; 2013.

Kumar J, Pathak AK, Verma A, Dwivedi S. Study of Incidence And Risk Factors of Chalazion in Bundelkhand Region. IOSR J Dent Med Sci. 2017;16(5):5-8.

Otulana T, Bodunde O, Ajibode H. Chalazion, a Benign Eyelid Tumour – The Sagamu Experience. Niger J Ophthalmol. 2009;16(2).

Mansour AM, Chan CC, Crawford MA, et al. Virus-induced chalazion. Eye. 2006;20(2):242-6.

Mustafa TA, Oriafage IH. Three methods of treatment of chalazia in children. Saudi Med J. 2001;22(11):968-72.

D’hermies F, Fayet B, Meyer A. Chalazion Mimicking an Eyelid Tumor. Journal francais d’ophtalmologie. 2004;27:202-5.

Mueller JB, McStay CM. Ocular Infection and Inflammation. Emerg Med Clin North Am. 2008;26(1):57-72.

Aoki M, Kawana S. Bilateral chalazia of the lower eyelids associated with pulmonary tuberculosis [8]. Acta Derm Venereol. 2002;82(5):386-7.

Mohammadpour I, Motazedian MH, Handjani F, Hatam GR. Cutaneous leishmaniasis of the eyelids: A case series with molecular identification and literature review. Korean J Parasitol. 2016;54(6):787-92.

Mittal R, Tripathy D, Sharma S, Balne PK. Tuberculosis of eyelid presenting as a chalazion. Ophthalmology. 2013;120(5).

Lai JJ, Chang P, Lai KP, Chen L, Chang C. The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res. 2012;304(7):499-510.

Imperato-Mc Ginley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab. 1993;76(2):524-8.

DeStafeno JJ, Kodsi SR, Primack JD. Recurrent Staphylococcus aureus chalazia in hyperimmuno-globulinemia e (Job’s) syndrome. Am J Ophthalmol. 2004;138(6):1057-8.

Chosidow O, Cribier B. Epidemiology of rosacea: Updated data. In: Annales de Dermatologie et de Venereologie. 2011: 138.

van Zuuren EJ. Rosacea. N Engl J Med. 2017;377(18):1754-64.

Sharma S. Ophthaproblem. Chalazion. Can Fam physician M. 1998;44.

Eltis M. Seborrheic blepharitis. Clin Refract Optom. 2012;23(3):74-7.

Downloads

Published

2018-10-25

How to Cite

Alsammahi, A., Aljohani, Z., Jaad, N., Abu Daia, O., Aldayhum, M., Almutairi, M., Basendwah, M., Alzahrani, R., & Alturki, M. (2018). Incidence and predisposing factors of chalazion. International Journal Of Community Medicine And Public Health, 5(11), 4979–4982. https://doi.org/10.18203/2394-6040.ijcmph20184253

Issue

Section

Review Articles